{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:43:33Z","timestamp":1790649813508,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T00:00:00Z","timestamp":1384300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0079141","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T23:06:41Z","timestamp":1384384001000},"page":"e79141","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Reduced Nasal Nitric Oxide Production in Cystic Fibrosis Patients with Elevated Systemic Inflammation Markers"],"prefix":"10.1371","volume":"8","author":[{"given":"Ruth K.","family":"Michl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hentschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen G.","family":"Mainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jcf.2012.07.001","article-title":"Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization","volume":"12","author":"K Aanaes","year":"2013","journal-title":"J Cyst Fibros"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/thx.2008.104711","article-title":"Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis","volume":"64","author":"JG Mainz","year":"2009","journal-title":"Thorax"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1378\/chest.07-1631","article-title":"Airway inflammation in cystic fibrosis","volume":"133","author":"A Elizur","year":"2008","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1569-1993(02)00072-3","article-title":"Cell and cytokine profile in nasal secretions in cystic fibrosis","volume":"1","author":"C Bergoin","year":"2002","journal-title":"J Cyst Fibros"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1440-1843.2005.00649.x","article-title":"Nasal wash as an alternative to bronchoalveolar lavage in detecting early pulmonary inflammation in children with cystic fibrosis","volume":"10","author":"PM Pitrez","year":"2005","journal-title":"Respirology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/thx.54.10.947","article-title":"Nasal nitric oxide in man","volume":"54","author":"JO Lundberg","year":"1999","journal-title":"Thorax"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1378\/chest.126.4.1054","article-title":"Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia","volume":"126","author":"R Corbelli","year":"2004","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/bbrc.1994.2169","article-title":"Expression of inducible nitric oxide in human lung epithelial cells","volume":"203","author":"RA Robbins","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1164\/ajrccm.151.6.7767536","article-title":"Elevated levels of exhaled nitric oxide in bronchiectasis","volume":"151","author":"SA Kharitonov","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/adc.75.4.323","article-title":"Exhaled nitric oxide in paediatric asthma and cystic fibrosis","volume":"75","author":"JO Lundberg","year":"1996","journal-title":"Arch Dis Child"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00011-006-6111-1","article-title":"Nitric oxide in upper airways inflammatory diseases","volume":"56","author":"M Maniscalco","year":"2007","journal-title":"Inflamm Res"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Boon M, Jorissen M, Proesmans M, De Boeck K (2012) Primary ciliary dyskinesia, an orphan disease. Eur J Pediatr.","DOI":"10.1007\/s00431-012-1785-6"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1378\/chest.117.4.1085","article-title":"Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype","volume":"117","author":"SR Thomas","year":"2000","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/adc.75.4.319","article-title":"Reduced upper airway nitric oxide in cystic fibrosis","volume":"75","author":"IM Balfour-Lynn","year":"1996","journal-title":"Arch Dis Child"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1099-0496(199709)24:3<173::AID-PPUL2>3.0.CO;2-O","article-title":"Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis","volume":"24","author":"H Grasemann","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/thorax.56.2.151","article-title":"Exhaled nitric oxide is reduced in infants with cystic fibrosis","volume":"56","author":"HE Elphick","year":"2001","journal-title":"Thorax"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Beiersdorf N, Schien M, Hentschel J, Pfister W, Markert UR, <etal>et al<\/etal>.. (2012) Soluble inflammation markers in nasal lavage from CF patients and healthy controls. J Cyst Fibros.","DOI":"10.1016\/j.jcf.2012.08.015"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","author":"S American Thoracic","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1034\/j.1399-3003.2000.16b09.x","article-title":"Characterization of exhaled nitric oxide: introducing a new reproducible method for nasal nitric oxide measurements","volume":"16","author":"JP Palm","year":"2000","journal-title":"Eur Respir J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2500\/105065899781367528","article-title":"Normal adult values, diurnal variation, and repeatability of nasal nitric oxide measurement","volume":"13","author":"J Bartley","year":"1999","journal-title":"Am J Rhinol"},{"key":"ref21","first-page":"625","article-title":"The functional development of the respiratory system from the period of gestation to adulthood","volume":"120","author":"G Polgar","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Zapletal A, \u0160am\u00e1nek M, Paul T (1987) Lung function in children and adolescents : methods, reference values. Basel; New York: Karger. viii, 220 p. p.","DOI":"10.1159\/isbn.978-3-318-04125-5"},{"key":"ref23","unstructured":"(2006) \u201cBMI classification\u201d, Global database on body mass index World Health Organization."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"TW Lee","year":"2003","journal-title":"J Cyst Fibros"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1183\/09031936.98.12061290","article-title":"Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis","volume":"12","author":"LP Ho","year":"1998","journal-title":"Eur Respir J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1378\/chest.06-2635","article-title":"Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids","volume":"131","author":"C Keen","year":"2007","journal-title":"Chest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/adc.78.1.49","article-title":"Nitric oxide metabolites in cystic fibrosis lung disease","volume":"78","author":"H Grasemann","year":"1998","journal-title":"Arch Dis Child"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1183\/09031936.04.00086104","article-title":"Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study","volume":"25","author":"H Grasemann","year":"2005","journal-title":"Eur Respir J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/(SICI)1096-9896(199803)184:3<323::AID-PATH2>3.0.CO;2-2","article-title":"Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis","volume":"184","author":"QH Meng","year":"1998","journal-title":"J Pathol"},{"key":"ref30","first-page":"921","article-title":"Nitric oxide is inactivated by the bacterial pigment pyocyanin","volume":"266","author":"JB Warren","year":"1990","journal-title":"Biochem J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/.61.4.533-616.1997","article-title":"Cell biology and molecular basis of denitrification","volume":"61","author":"WG Zumft","year":"1997","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2012.04.011","article-title":"Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response","volume":"11","author":"HK Johansen","year":"2012","journal-title":"J Cyst Fibros"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ismej.2011.83","article-title":"Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection","volume":"6","author":"SK Hansen","year":"2012","journal-title":"ISME J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/thx.2005.049536","article-title":"Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis","volume":"61","author":"M Kappler","year":"2006","journal-title":"Thorax"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Jaffe A, Brush A (2005) Macrolides in cystic fibrosis. In: Rubin BK, Tamaoki J, editors. Antibiotics as anti-inflammatory and immunomodulatory agents. Basel: Berghauser Verlage. 167\u2013191.","DOI":"10.1007\/3-7643-7310-5_11"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Ratjen F, Saiman L, Mayer-Hamblett N, Lands LC, Kloster M, <etal>et al<\/etal>.. (2012) Effect of azithromycin on systemic markers of inflammation in cystic fibrosis patients uninfected with Pseudomonas aeruginosa. Chest.","DOI":"10.1378\/chest.12-0628"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1183\/09031936.04.00084304","article-title":"Azithromycin for cystic fibrosis","volume":"24","author":"KW Southern","year":"2004","journal-title":"Eur Respir J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1399-3003.2000.16a17.x","article-title":"Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment","volume":"16","author":"Q Jobsis","year":"2000","journal-title":"Eur Respir J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1164\/ajrccm.184.9.1089","article-title":"Cystic fibrosis upper airways primary colonization with Pseudomonas aeruginosa: eradicated by sinonasal antibiotic inhalation","volume":"184","author":"JG Mainz","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2500\/ajra.2013.27.3829","article-title":"The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis","volume":"27","author":"K Aanaes","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4193\/Rhin12.207","article-title":"Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?","volume":"51","author":"K Aanaes","year":"2013","journal-title":"Rhinology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0079141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T13:26:00Z","timestamp":1688649960000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0079141"}},"subtitle":[],"editor":[{"given":"Shama","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,13]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0079141","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,13]]}}}